sec.224Chief executive to keep database

sec.224 Chief executive to keep database

The chief executive must keep an electronic database (the monitored medicines database ) to record information about the prescription and supply of monitored medicines. The purposes of keeping the monitored medicines database are— to promote safe practices for the therapeutic use of monitored medicines and reduce community harm caused by monitored medicines; and to ensure particular health practitioners are complying with this Act, a corresponding law or any applicable requirements under the Health Practitioner Regulation National Law ; and to facilitate— the assessment or investigation of health service complaints under the Health Ombudsman Act 2013 ; and the investigation or monitoring of persons subject to actions or orders under that Act; and to enable particular health practitioners to access the database to record and review information for the therapeutic treatment of persons; and to facilitate evaluation and research into monitored medicines; and to facilitate national consistency in the therapeutic use of monitored medicines; and any other purpose prescribed by regulation. s 224 amd 2020 No. 31 s 19H (sec.224-ssec.1) The chief executive must keep an electronic database (the monitored medicines database ) to record information about the prescription and supply of monitored medicines. (sec.224-ssec.2) The purposes of keeping the monitored medicines database are— to promote safe practices for the therapeutic use of monitored medicines and reduce community harm caused by monitored medicines; and to ensure particular health practitioners are complying with this Act, a corresponding law or any applicable requirements under the Health Practitioner Regulation National Law ; and to facilitate— the assessment or investigation of health service complaints under the Health Ombudsman Act 2013 ; and the investigation or monitoring of persons subject to actions or orders under that Act; and to enable particular health practitioners to access the database to record and review information for the therapeutic treatment of persons; and to facilitate evaluation and research into monitored medicines; and to facilitate national consistency in the therapeutic use of monitored medicines; and any other purpose prescribed by regulation.

• (a) to promote safe practices for the therapeutic use of monitored medicines and reduce community harm caused by monitored medicines; and
• (b) to ensure particular health practitioners are complying with this Act, a corresponding law or any applicable requirements under the Health Practitioner Regulation National Law ; and
• (c) to facilitate— (i) the assessment or investigation of health service complaints under the Health Ombudsman Act 2013 ; and (ii) the investigation or monitoring of persons subject to actions or orders under that Act; and
• (i) the assessment or investigation of health service complaints under the Health Ombudsman Act 2013 ; and